Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New 90-Minute test could save lives in sepsis emergencies

NCT ID NCT06219135

Diagnosis Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new method called IDBIORIV that can identify the germ causing a bloodstream infection and determine which antibiotics will work in just 90 minutes, compared to the usual 24-48 hours. Sepsis is a life-threatening condition that affects millions worldwide, and faster diagnosis can lead to quicker, more effective treatment and higher survival rates. The study will enroll about 1,372 adults and children with sepsis to see how well this new method compares to current lab techniques.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,372 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study will focus on adult and pediatric patients hospitalized in 23 clinical departments of the Hospices Civils de Lyon and presenting a first positive blood culture detected on the microbiology laboratory of the Institut des Agents Infectieux.

Ages

1 day and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult or child patient * Hospitalized in one of the departments registered with Hospices Civils de Lyon * Showing signs of infection * Confirmed by a 1st positive blood culture * Patient or close relative (trustworthy person or family member) or holder of parental authority who has given his or her non-objection after receiving the information note Exclusion Criteria: * Patients under court protection * Patients under guardianship or curatorship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sepsis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Sepsis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    23 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Charpennes Hospital

    RECRUITING

    Villeurbanne, 69100, France

  • Croix Rousse Hospital

    RECRUITING

    Lyon, 69004, France

  • Croix Rousse Hospital

    NOT_YET_RECRUITING

    Lyon, 69004, France

  • Croix Rousse Hospital

    RECRUITING

    Lyon, 69004, France

  • Croix Rousse Hospital

    RECRUITING

    Lyon, 69004, France

  • Croix Rousse Hospital

    RECRUITING

    Lyon, 69004, France

  • Croix Rousse Hospital

    RECRUITING

    Lyon, 69004, France

  • Croix Rousse Hospital

    NOT_YET_RECRUITING

    Lyon, 69004, France

  • Edouard Herriot Hospital

    RECRUITING

    Lyon, 69003, France

  • Edouard Herriot Hospital

    RECRUITING

    Lyon, 69003, France

  • Edouard Herriot Hospital

    NOT_YET_RECRUITING

    Lyon, 69003, France

  • Edouard Herriot Hospital

    NOT_YET_RECRUITING

    Lyon, 69003, France

  • Femme Mère Enfant Hospital

    RECRUITING

    Bron, 69394, France

  • Femme Mère enfant Hospital

    RECRUITING

    Bron, 69394, France

  • Femme Mère enfant Hospital

    NOT_YET_RECRUITING

    Bron, 69394, France

  • Louis Pradel Hospital

    RECRUITING

    Bron, 69394, France

  • Louis Pradel Hospital

    RECRUITING

    Bron, 69394, France

  • Louis Pradel Hospital

    RECRUITING

    Bron, 69394, France

  • Lyon Sud Hospital

    RECRUITING

    Pierre-Bénite, 69495, France

  • Lyon Sud Hospital

    RECRUITING

    Pierre-Bénite, 69495, France

  • Lyon Sud Hospital

    NOT_YET_RECRUITING

    Pierre-Bénite, 69495, France

  • Lyon Sud Hospital

    NOT_YET_RECRUITING

    Pierre-Bénite, France

  • Pierre Wertheimer Hospital

    RECRUITING

    Bron, 69394, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.